
Opinion|Videos|July 10, 2024
Dr Dempsey Shares How the Type of Endocrine Therapy Can Impact Toxicities Seen in Her Patients
Dr. Dempsey details how different types of endocrine therapies have impacted toxicities within her patients.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- In the monarchE and NATALEE trials, the endocrine therapy allowed was different. How did the type of endocrine therapy used impact toxicities seen, and how has that translated to your practice when selecting endocrine therapies?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Fuzuloparib Monotherapy Improves PFS in Advanced Ovarian Cancer, but Adding Apatinib Offers No Additional Benefit
2
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
3
Top 5 Inflammation Articles of 2025
4
House Republicans Block Vote on ACA Subsidy Extension
5







































